American Society of Hematology Announces 2021 Scholar Award Recipients

(WASHINGTON, January 13, 2021) — The American Society of Hematology (ASH) today announced the 36 recipients of its 2021 Scholar Awards. One of ASH’s most prestigious research award programs, the ASH Scholar Awards financially support fellows and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators. 

Each Scholar Award provides $100,000 for the Fellow level, $125,000 for the new Fellow to Faculty Scholars level, or $150,000 for the Junior Faculty level. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH gratefully acknowledges this year’s corporate supporters: AstraZeneca, Bristol Myers Squibb, Janssen Biotech, Inc., Merck & Co., Inc., and Pharmacyclics LLC.

“When you’re beginning your research career, receiving funding from an organization like ASH not only provides the necessary support to pursue your goals but it also instills confidence that your work is worthwhile,” said 2021 ASH President Martin S. Tallman, MD, of Memorial Sloan Kettering Cancer Center. “The ASH Scholar Award has been a turning point in the careers of fellows and early career faculty who have gone on to become leaders in our field. We congratulate this year’s recipients and look forward to watching their promising research careers unfold.”

The 2021 Scholar Awards recipients are:

Basic/Translational Research Fellows

Casey Katerndahl, PhD
Washington University in St. Louis

Christine Zhang, PhD
Washington University School of Medicine

Diu Nguyen, DPhil
Memorial Sloan Kettering Cancer Center

Eugene Khandros, MD, PhD
The Children's Hospital of Philadelphia

Han Dong, PhD
Dana-Farber Cancer Institute

Kristen Schratz, MD
Johns Hopkins University School of Medicine

Marlise L. Guerrero Schimpf, PhD
University of Miami Miller School of Medicine

Moua Yang, PhD
Beth Israel Deaconess Medical Center

Scott Millman, MD, PhD
Memorial Sloan Kettering Cancer Center

Yimeng Gao, PhD
Yale University

Basic/Translational Fellow to Faculty

Aaron Viny, MD
Columbia University Irving Medical Center

Brooke Sadler, PhD
Washington University in St. Louis

Coraline Mlynarczyk, PhD
Weill Cornell Medicine

Courtney Jones, PhD
University Health Network

Elisa Ten Hacken, PhD
Dana-Farber Cancer Institute

Franco Izzo, PhD
Weill Cornell Medicine

Roger Belizaire, MD, PhD
Brigham and Women's Hospital

Samuel Ng, MD, PhD
Dana-Farber Cancer Institute

Basic/Translational Junior Faculty

Ansuman Satpathy, MD, PhD
Stanford University

Dang Nguyen, PhD
University of Minnesota

Jeevisha Bajaj, PhD
University of Rochester Medical Center

Koichi Takahashi, MD, PhD
The University of Texas MD Anderson Cancer Center

Lisa Roth, MD
Weill Cornell Medicine

Rui Lu, PhD
University of Alabama At Birmingham

Satheesh Chonat, MD
Emory University School of Medicine

Shannon Buckley, PhD
University of Nebraska Medical Center

Stanley Lee, PhD
Fred Hutchinson Cancer Research Center

Clinical Fellows

Ghadeer Dawwas, PhD
University of Pennsylvania

Julia Xu, MD
National Institutes of Health

Roni Shouval, MD, PhD
Memorial Sloan Kettering Cancer Center

Clinical Junior Faculty

Aimee Talleur, MD
St. Jude Children's Research Hospital

Ami Patel, MD
Huntsman Cancer Institute

Eboni Lance, MD, PhD
Hugo W. Moser Research Institute At Kennedy Krieger, Inc.

Oreofe Odejide, MD
Dana-Farber Cancer Institute

Richard Lin, MD, PhD
Memorial Sloan Kettering Cancer Center

Shruti Chaturvedi, MBBS
Johns Hopkins University School of Medicine

The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, and Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.

Contact

Amanda Szabo
American Society of Hematology
[email protected]